Dacula, Sittie Alisha A.
HRN: 21-57-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/20/2022
08/27/2022
IVTT
200mg
Q8
NEC
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes